Solel Partners’s Herbalife HLF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.4M Hold
1,860,615
5.86% 9
2025
Q4
$24M Buy
1,860,615
+191,210
+11% +$2.02M 3.88% 13
2025
Q3
$14.1M Hold
1,669,405
2.71% 14
2025
Q2
$14.4M Buy
1,669,405
+262,614
+19% +$1.95M 2.5% 14
2025
Q1
$12.1M Buy
1,406,791
+237,386
+20% +$1.69M 2.25% 16
2024
Q4
$7.82M Hold
1,169,405
1.53% 14
2024
Q3
$8.41M Hold
1,169,405
1.65% 16
2024
Q2
$12.2M Hold
1,169,405
1.98% 16
2024
Q1
$11.8M Hold
1,169,405
1.95% 16
2023
Q4
$17.8M Hold
1,169,405
2.51% 18
2023
Q3
$16.4M Hold
1,169,405
2.44% 19
2023
Q2
$15.5M Hold
1,169,405
2.44% 18
2023
Q1
$18.8M Hold
1,169,405
3.85% 12
2022
Q4
$17.4M Sell
1,169,405
-150,000
-11% -$2.61M 3.9% 12
2022
Q3
$26.2M Hold
1,319,405
4.72% 8
2022
Q2
$27M Buy
1,319,405
+1,214,405
+1,157% +$30M 4.97% 7
2022
Q1
$3.19M Buy
+105,000
New +$4.11M 0.69% 18
2021
Q4
Sell
-1,000,905
Closed -$42.4M 21
2021
Q3
$42.4M Buy
1,000,905
+205,905
+26% +$10.2M 8.54% 4
2021
Q2
$41.9M Buy
795,000
+424,600
+115% +$21.1M 10.15% 4
2021
Q1
$16.4M Buy
+370,400
New +$18.3M 4.1% 9

Other funds holding HLF

Solel Partners's HLF Position: Q1 2026 in Review

Solel Partners held its Herbalife (HLF) position steady in Q1 2026 at 1,860,615 shares worth $27.4M. The position accounts for 5.86% of the portfolio, ranked #9.

Solel Partners first reported a position in HLF in Q1 2021 and has held it in 20 quarters since. The position peaked at $42.4M in Q3 2021. 252 funds tracked by Wall St. Rank hold HLF as of Q1 2026.

  • Solel Partners held 1,860,615 shares of Herbalife worth $27.4M as of Q1 2026.
  • Solel Partners left its Herbalife share count unchanged in Q1 2026.
  • Herbalife made up 5.86% of Solel Partners's portfolio in Q1 2026, its #9 holding.
  • Solel Partners first reported a position in Herbalife in Q1 2021 and has held it in 20 quarters since.
  • Solel Partners's Herbalife position peaked at $42.4M in Q3 2021.
  • 252 funds tracked by Wall St. Rank held Herbalife as of Q1 2026.

Based on Solel Partners's 13F filing for Q1 2026, filed 15 May 2026.